Consider contacting your GP if you experience: Persistent or significant decrease in libido that affects your quality of life or relationships Changes in sexual function accompanied by other concerning symptoms (mood changes, fatigue, pain) Erectile dysfunction or other physical difficulties with sexual activity Relationship difficulties related to changes in intimacy Symptoms suggesting hormonal imbalance (irregular periods, hot flushes, changes in body hair) Seek immediate medical attention if you experience: Severe, persistent abdominal pain, especially if radiating to the back, with or without vomiting (possible pancreatitis) Right upper abdominal pain, jaundice (yellowing of skin/eyes), or fever (possible gallbladder disease) Your healthcare provider can conduct a comprehensive assessment to identify potential contributing factors: Medication review : Evaluating all current medications, as some drugs (antidepressants, blood pressure medications, hormonal contraceptives) are known to affect libido Physical examination : Checking for signs of hormonal imbalance or other medical conditions Blood tests : Assessing hormone levels (testosterone, thyroid function), vitamin deficiencies, or metabolic markers if clinically indicated Mental health evaluation : Screening for depression, anxiety, or stress that may impact sexual function For erectile dysfunction, your GP may assess cardiovascular risk factors and consider referral if symptoms persist or if low testosterone is suspected
Plaintiffs allege that GLP-1 agonists drug manufacturers were aware of the link between these medications and gastroparesis based on clinical trial data yet chose not to prominently disclose or warn about this risk
doi: 10.1016/j.bbrc.2015.01.098 184 SpielmanLJGibsonDLKlegerisA
Rejuvenate MedSpa is excited to offer weight loss options with Semaglutide and Tirzepatide (Wegovy, Ozempic, Zepbound)
Remarkably, increasing evidence also points toward GPX4 protein degradation as a means to incite cancer cell ferroptosis and apoptosis in hepatocellular carcinoma and breast cancer cells [221,222,223]
They found only one small exploratory ulcerative-colitis study with too little detail for firm conclusions, no clinical studies in Crohn's disease, and continuing concerns about product quality and safety
